News
ABS-CBN on MSN8h
US approves Gilead's twice-yearly injection to prevent HIVThe US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback